+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 45Years
All Genders
Healthy Volunteers
ID06935682

Phase 1 Study to Evaluate Safety and Pharmacokinetics of Y-4 Tablets in Healthy Chinese Adults Aged 18 to 45

Led by Beijing Tiantan Hospital · Updated on 2025-04-20

36

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and pharmacokinetics of Y-4 tablets, a new fixed-dose combination containing pregabalin and riluzole, in healthy Chinese adults aged 18 to 45 years. This randomized, double-blind, placebo-controlled, dose-escalation study aims to understand how these drugs behave in the body after single and multiple doses, providing important information about their effects in healthy individuals. The study will enroll 36 healthy adult participants divided into three dose groups, each with 12 subjects balanced by gender. Participants will receive either Y-4 tablets or placebo in both single-dose and multiple-dose phases. The single dose is given on the morning of Day 1 after fasting, and multiple doses are given twice daily from Day 5 to Day 9, then once on Day 10, totaling 11 doses. Dose levels include 75 mg18.75 mg, 112.5 mg28.125 mg, and 150 mg37.5 mg of pregabalin and riluzole respectively. Participants will be screened 14 days before dosing and admitted the day before the first dose for fasting. They will be monitored for safety and tolerability through clinical assessments such as laboratory tests, vital signs, ECGs, physical exams, and scales from Day 1 to approximately Day 19. A follow-up call will occur about 7 days after discharge. The study includes careful evaluation of adverse events and pharmacokinetic parameters during and after dosing, with the total participation lasting about three weeks.

CONDITIONS

Brief Title

Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects

Research Team

Y

Ya Shu Li, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here